Immunosuppression Screen

References, Ethics and Privacy

Ethics

"Immunosuppression screen - a risk management tool for patients" has been reviewed and approved by the Sydney South West Area Health Service Human Research Ethics Commitee - CRGH Zone: Protocol number: CH62/6/2011-007 - S. Riminton.


Privacy

"Immunosuppression screen - a risk management tool for patients" collects no identifying personal information and does not require patient consent.


Reference Information

Immunosuppression Screen
Riminton DS et al, Managing the risks of Immunosuppression. Current Opinion in Neurology, 2011, 24: 217-223 http://www.ncbi.nlm.nih.gov/pubmed/21519254

Cardiovascular Risk Calculator
The screening tool uses information from the "New Zealand Cardiovascular Risk Calculator"

BMD Details
Hoes JN, et al. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2007; 66:1560�1567.

BMI Classification
World Health Organization

Vaccination requirements
Rahier JF et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology 2010, 49, 1815-1827